» Articles » PMID: 19460107

Intestinal Immune Activation in Presumed Post-infectious Functional Dyspepsia

Overview
Date 2009 May 23
PMID 19460107
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Functional dyspepsia (FD) symptoms may develop after an acute gastroenteritis. In post-infectious (PI) irritable bowel syndrome, persisting low-grade colonic inflammation and increased enterochromaffine cells (EC) counts have been reported. The aim was to compare signs of inflammation and EC hyperplasia on duodenal biopsies in presumed PI-FD and unspecified-onset (U-)FD. Duodenal biopsies were obtained in 12 U-FD and 12 PI-FD (on average 13 months after the acute event) patients. The presence of intra-epithelial, intravillar, and the number of CD3, CD4, CD8 and CD68+ cells per crypts, and the mean number of Chromogranine A (CA) positive cells per villus were compared. We also measured gastric emptying and assessed proximal stomach function with a barostat. Data are shown as mean +/- SEM. Focal aggregates of T cells and focal CD8+ aggregates, were found in PI-FD but not in U-FD patients (respectively 5/12 vs 0/12, P = 0.02 and 5/9 vs 0/11, P < 0.01). In patients with focal aggregates, gastric emptying was delayed (189 +/- 37 min vs 98 +/- 11 min, P = 0.002). The number of CD4+ cells per crypt (0.52 +/- 1.6 vs 1.22 +/- 2.18, P = 0.04), and the number of intravillar CD4+ cells (0.5 +/- 0.2 vs 2.7 +/- 0.7, P = 0.01) were reduced, while the number of CD68+ cells per crypt was increased (0.64 +/- 0.13 vs 0.40 +/- 0.05, P = 0.03) in PI-FD. The number of EC and CA were comparable. PI-FD is associated with persisting focal T-cell aggregates, decreased CD4+ cells and increased macrophage counts surrounding the crypts. This may indicate impaired ability of the immune system to terminate the inflammatory response after acute insult.

Citing Articles

Characteristics and Risk Factors of Functional Dyspepsia Fulfilling the Rome IV Criteria Overlapping With Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, and Functional Constipation in South China.

Long Y, Xu W, Li L, He H, Wang J, Shan G J Neurogastroenterol Motil. 2023; 30(2):184-193.

PMID: 37788825 PMC: 10999841. DOI: 10.5056/jnm23084.


Long-lasting dyspeptic symptoms - another consequence of the COVID-19 pandemic?.

Nazarewska A, Lewandowski K, Kaniewska M, Tulewicz-Marti E, Wiecek M, Szwarc P Prz Gastroenterol. 2023; 18(2):175-182.

PMID: 37538287 PMC: 10395060. DOI: 10.5114/pg.2023.129414.


Gastroparesis: The Complex Interplay with Microbiota and the Role of Exogenous Infections in the Pathogenesis of the Disease.

Mandarino F, Sinagra E, Barchi A, Verga M, Brinch D, Raimondo D Microorganisms. 2023; 11(5).

PMID: 37317096 PMC: 10221816. DOI: 10.3390/microorganisms11051122.


Pharmacological Treatment of Functional Dyspepsia: An Old Story Revisited or a New Story to Be Told? A Clinical Review.

Chaves J, Pita I, Libanio D, Pimentel-Nunes P GE Port J Gastroenterol. 2023; 30(2):86-97.

PMID: 37008521 PMC: 10050843. DOI: 10.1159/000526674.


Understanding neuroimmune interactions in disorders of gut-brain interaction: from functional to immune-mediated disorders.

Vanuytsel T, Bercik P, Boeckxstaens G Gut. 2023; 72(4):787-798.

PMID: 36657961 PMC: 10086308. DOI: 10.1136/gutjnl-2020-320633.